Research Funding Scarcer for Early-Stage Biotech Companies

Research Funding Scarcer for Early-Stage Biotech Companies

Amgen via Bloomberg

Of the more than 270 publicly traded biotechs in the U.S., only about 40 - such as Amgen Inc., Gilead Sciences Inc. and Biogen Idec Inc. - are profitable, Bloomberg data show.